Midatech Pharma PLC
LSE:MTPH
Midatech Pharma PLC
LSE:MTPH
Price:
15.1
GBX
1 489.47%
Market Closed
Market Cap:
£26.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Midatech Pharma PLC
LSE:MTPH
|
UK |
|
Kailong High Technology Co Ltd
SZSE:300912
|
CN |
|
Guangdong Xinhui Meida Nylon Co Ltd
SZSE:000782
|
CN |
|
F
|
Franchetti SpA
MIL:FCH
|
IT |
|
Schwaelbchen Molkerei Jakob Berz AG
F:SMB
|
DE |
|
Vidrala SA
OTC:VDRFF
|
ES |
|
A
|
Arribatec Group ASA
OSE:ARR
|
NO |
|
China Resources Cement Holdings Ltd
HKEX:1313
|
HK |
|
V
|
Vikas Ecotech Ltd
BSE:530961
|
IN |
|
E
|
Ekarat Engineering PCL
SET:AKR
|
TH |
|
E
|
Easy Software AG
XHAM:ESY
|
DE |
|
S
|
Sangsangin Co Ltd
KOSDAQ:038540
|
KR |
|
A
|
African Equity Empowerment Investments Ltd
JSE:AEE
|
ZA |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
Income Statement
Earnings Waterfall
Midatech Pharma PLC
Midatech Pharma PLC
Income Statement
Midatech Pharma PLC
Midatech Pharma PLC
Currency: GBP
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
1
N/A
|
0
-49%
|
1
+69%
|
|
| Operating Income | ||||
| Operating Expenses |
(12)
|
(11)
|
(8)
|
|
| Selling, General & Administrative |
(4)
|
(5)
|
(3)
|
|
| Research & Development |
(8)
|
(6)
|
(5)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
|
| Operating Income |
(11)
N/A
|
(11)
+6%
|
(7)
+34%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
(0)
|
1
|
|
| Non-Reccuring Items |
0
|
(12)
|
0
|
|
| Pre-Tax Income |
(11)
N/A
|
(23)
-115%
|
(6)
+74%
|
|
| Net Income | ||||
| Tax Provision |
2
|
1
|
1
|
|
| Income from Continuing Operations |
(9)
|
(22)
|
(5)
|
|
| Net Income (Common) |
(10)
N/A
|
(22)
-120%
|
(5)
+75%
|
|
| EPS (Diluted) |
-11
N/A
|
-10.36
+6%
|
-1.36
+87%
|
|
Switch to:
Switch to:
See Also
Discover More
